Safety and efficacy of CL-108 for moderate-to-severe acute pain with reduction of opioid-induced nausea and vomiting

Hersh E, Schachtel B, Daniels S, Muse D, Patrick K, Zuniga J, Bennett J, Schachtel E, Papas A. Poster presented at: Pain Week 2014; September 2-6, 2014; Las Vegas, NV.